Accretion Pharmaceuticals Ltd vs Syschem India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 109.4 as of 05 May 15:30 . The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Syschem (India) Ltd changed from 33.7 on March 2023 to 332.4 on March 2025 . This represents a CAGR of 114.46% over 3 years The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Syschem (India) Ltd changed from ₹ 16.16 crore on March 2021 to ₹ 159.08 crore on March 2025 . This represents a CAGR of 57.99% over 5 years The revenue of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syschem (India) Ltd for the Dec '25 is ₹ 141.5 crore as compare to the Sep '25 revenue of ₹ 103.61 crore. This represent the growth of 36.57% The ebitda of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syschem (India) Ltd for the Dec '25 is ₹ 5.96 crore as compare to the Sep '25 ebitda of ₹ 3.31 crore. This represent the growth of 80.06% The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Syschem (India) Ltd changed from ₹ 0.14 crore to ₹ 4.17 crore over 7 quarters. This represents a CAGR of 595.49% The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Syschem (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Syschem (India) Ltd

Syschem (India) Limited, formerly known as Anil Pesticides Limited was incorporated on 31 December, 1993.
The name of the Company was changed from Anil Pesticides Limited to Syschem (India) Limited on February 17, 2003.
Company is engaged in the business of manufacturing of API / Intermediates.
It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt.
Panchkula (Haryana). In 1996 the company went for launching new product called Monocrotophos and production was commissioned in 1998. The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000. The company introduced new products namely Deta,DETC and Ethion in 2001.

FAQs for the comparison of Accretion Pharmaceuticals Ltd and Syschem (India) Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Syschem (India) Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 126 Cr while Market cap of Syschem (India) Ltd is 247 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Syschem (India) Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Syschem (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Syschem (India) Ltd?

As of May 5, 2026, the Accretion Pharmaceuticals Ltd stock price is INR ₹114.05. On the other hand, Syschem (India) Ltd stock price is INR ₹50.52.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Syschem (India) Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Syschem (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.